Insights into the Molecular Mechanism of Pulmonary Vein Stenosis in Pediatric Patients with Congenital Heart Disease

Strategic Insights -

A new study on pediatric pulmonary vein stenosis (PVS) has been published, providing a comprehensive understanding of the molecular mechanisms underlying the development and trajectory of PVS. The research, conducted at Texas Children's Hospital, reveals that aggressive primary pulmonary vein stenosis (PPVS) is associated with changes in the expression of genes related to extracellular matrix regulation, mechanosensitive receptors, and cardiac muscle contractility. These findings suggest that the aggressive PPVS phenotype may be driven by an overexpression of PIEZO1, a mechanosensitive receptor present in endothelial cells, in response to elevated shear stress.

Key Takeaways:

  • The study characterizes the transcriptome of clinical and phenotypic subtypes of PVS, highlighting the differences in gene expression between primary and postrepair PVS, as well as aggressive and non-aggressive clinical phenotypes.
  • Bulk RNA sequencing analysis revealed notable changes in the genes associated with extracellular matrix regulation and PIEZO1 in aggressive primary pulmonary vein stenosis (PPVS) compared to non-aggressive PPVS.
  • The study identifies an overexpression of PIEZO1 as a potential mechanism for aggressive PPVS phenotype, which may be attributed to an increase in extracellular matrix production and subsequent activation of intracellular signaling pathways.
  • The research concludes that the clinical and therapeutic relevance of PIEZO1 warrant further investigation to understand the molecular mechanism of PVS in pediatric patients with congenital heart disease.
  • The study's findings provide new insights into the understanding of PVS, which may lead to the development of novel therapeutic strategies for the treatment of this condition.
  • The research highlights the importance of understanding the molecular mechanisms underlying PVS to improve the diagnosis, treatment, and outcomes of pediatric patients with congenital heart disease.

Statistics:

  • The study analyzedhuman pulmonary vein tissue samples obtained from surgical interventions for pediatric patients with PVS.
  • The research identified differences in the expression of genes associated with extracellular matrix regulation and PIEZO1 in aggressive primary pulmonary vein stenosis (PPVS) compared to non-aggressive PPVS.
  • The study found notable changes in cardiac muscle contractility, calcium handling, respiratory and energy metabolism in aggressive PPVS phenotype.
  • The research suggests that the aggressive PPVS phenotype may be driven by an overexpression of PIEZO1 in response to elevated shear stress, leading to reduced contractility and intracellular calcium transients within cardiomyocytes.

Sources:

  • "Insights into the molecular mechanism of pulmonary vein stenosis in pediatric patients with congenital heart diseaseCentral MessagePerspective" by MD Alyssa B. Kalustian et al., published in JTCVS Open, 2025, 26():166-181.
  • "Study Data from Texas Children's Hospital Update Knowledge of Angiology" by NewsRx, published in Cardiovascular Week, September 15, 2025, p 3084.